Cellebrite DI (CLBT) Current Assets (2020 - 2025)

Cellebrite DI has reported Current Assets over the past 6 years, most recently at $575.8 million for Q4 2025.

  • Quarterly results put Current Assets at $575.8 million for Q4 2025, up 1.45% from a year ago — trailing twelve months through Dec 2025 was $575.8 million (up 1.45% YoY), and the annual figure for FY2025 was $575.8 million, up 1.45%.
  • Current Assets for Q4 2025 was $575.8 million at Cellebrite DI, up from $567.6 million in the prior quarter.
  • Over the last five years, Current Assets for CLBT hit a ceiling of $575.8 million in Q4 2025 and a floor of $273.2 million in Q4 2021.
  • Median Current Assets over the past 5 years was $422.1 million (2023), compared with a mean of $426.9 million.
  • Biggest five-year swings in Current Assets: decreased 15.75% in 2021 and later soared 42.63% in 2023.
  • Cellebrite DI's Current Assets stood at $273.2 million in 2021, then increased by 8.32% to $295.9 million in 2022, then skyrocketed by 42.63% to $422.1 million in 2023, then skyrocketed by 34.47% to $567.6 million in 2024, then rose by 1.45% to $575.8 million in 2025.
  • The last three reported values for Current Assets were $575.8 million (Q4 2025), $567.6 million (Q4 2024), and $422.1 million (Q4 2023) per Business Quant data.